Show
Sort by
-
The oncologic role of local treatment in primary metastatic prostate cancer
-
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series
-
- Journal Article
- A1
- open access
Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome
-
Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy : first results of the randomized trial SAKK 09/10
-
Can we expand active surveillance criteria to include biopsy Gleason 3 + 4 prostate cancer? A multi-institutional study of 2,323 patients
-
Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer : a 10-years single centre experience
-
Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire
-
- Journal Article
- A1
- open access
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study
-
- Journal Article
- A1
- open access
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
-
Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?